Lantheus Holdings (LNTH) Cash from Financing Activities (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Cash from Financing Activities came in at $4.5 million in Q2 2026, up 104.58% year-over-year from $2.2 million in Q2 2025, and up 138.76% quarter-over-quarter from -$11.6 million in Q1 2026.
Analysis
Lantheus Holdings (LNTH) Cash from Financing Activities (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Cash from Financing Activities for 13 consecutive years, with $4.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Financing Activities rose 104.58% year-over-year to $4.5 million in Q2 2026; TTM through Jun 2026 was -$207.1 million, a 5.2% increase from a year earlier, with the FY2025 full-year figure at -$316.6 million, down 167.08% from the prior year.
- Cash from Financing Activities was $4.5 million for Q2 2026 at Lantheus Holdings, up from -$11.6 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $317.8 million in Q4 2022 and troughed at -$103.7 million in Q4 2024.
- A 5-year average of -$8.0 million and a median of -$3.1 million in 2022 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities surged 15235.24% in 2022 and slumped 99507.07% in 2025, its largest moves.
- Over 5 years, Cash from Financing Activities stood at $317.8 million in 2022, then sank by 100.14% to -$450000.0 in 2023, then plunged by 22935.33% to -$103.7 million in 2024, then increased by 2.77% to -$100.8 million in 2025, then jumped by 104.47% to $4.5 million in 2026.
- The last three Cash from Financing Activities figures came in at $4.5 million (Q2 2026), -$11.6 million (Q1 2026), and -$100.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | -236.00 Mn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | 4.51 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | -300,000.00 |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | 3.95 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | 880,000.00 |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | -1.20 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | 200.60 Mn |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn | -22.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.51 Mn |
| Mar 31, 2026 | -11.62 Mn |
| Dec 31, 2025 | -100.79 Mn |
| Sep 30, 2025 | -99.17 Mn |
| Jun 30, 2025 | -98.41 Mn |
| Mar 31, 2025 | -18.22 Mn |
| Dec 31, 2024 | -103.66 Mn |
| Sep 30, 2024 | 1.87 Mn |
| Jun 30, 2024 | 99,000.00 |
| Mar 31, 2024 | -16.85 Mn |
| Dec 31, 2023 | -450,000.00 |
| Sep 30, 2023 | 108,000.00 |
| Jun 30, 2023 | -4.05 Mn |
| Mar 31, 2023 | -8.67 Mn |
| Dec 31, 2022 | 317.84 Mn |
| Sep 30, 2022 | -1.96 Mn |
| Jun 30, 2022 | -2.01 Mn |
| Mar 31, 2022 | -2.18 Mn |
| Dec 31, 2021 | -2.10 Mn |
| Sep 30, 2021 | -1.73 Mn |